MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
6.93
+0.71 (11.41%)
At close: Nov 6, 2026, 4:00 PM EST
7.14
+0.21 (3.03%)
Pre-market: Nov 9, 2026, 4:28 AM EST
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year. That makes MapLight Therapeutics the 29,634th largest employer in the world and 3,760th in the United States.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,728,023
Market Cap
385.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 161 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Precision BioSciences | 69 |
| Rezolute | 63 |
| AgomAb Therapeutics NV | 62 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
MPLT News
- 4 weeks ago - MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics - GlobeNewsWire
- 4 weeks ago - MapLight Therapeutics initiated with a Neutral at Guggenheim - TheFly
- 4 weeks ago - MapLight Therapeutics initiated with a Neutral at Guggenheim - TheFly
- 7 weeks ago - MapLight Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - MapLight Therapeutics files to sell 13.18M shares of common stock for holders - TheFly
- 2 months ago - MapLight Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - MapLight Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - MapLight Therapeutics price target lowered to $43 from $45 at Needham - TheFly